Screener
BillionToOne, Inc. BLLN Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Clinical trial support and other services | $1.54M+98.6% | $1.14M+61.0% | $810K+6.2% | $761K+11.9% | $774K— | |
| Oncology | $13.66M+176% | $10.72M+392% | $9.14M+736% | $8.69M+664% | $4.95M— | |
| Prenatal | $94.25M+54.9% | $96.53M+72.1% | $86.1M+99.2% | $74.07M+102% | $60.85M— |
FAQ
- How does BillionToOne, Inc. break its business down?
- BillionToOne, Inc. (BLLN) reports revenue by product across 3 parts — Clinical trial support and other services, Oncology and Prenatal. Each is extracted from the segment footnotes and tracked over time.
- Where does BillionToOne, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in BillionToOne, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
